Procurement Summary
Country : Brazil
Summary : Acquisition of Group 2 Medicines from the Specialized Component of Ceaf Pharmaceutical Assistance, Aiming to Meet the Needs of the Demands of the Superintension Superintendence Suaf, C ...
Deadline : 21 Jul 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 122145907
Document Ref. No. : 90024/2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of Group 2 Medicines of the Specialized Component of CEAF Pharmaceutical Assistance, aiming to meet the needs of the demands of the SUAF Pharmaceutical Assistance Superintendence, according to the conditions, specifications and quantities discriminated against in Reference Term (Annex I) of this Notice.
UASG Code: 425128
Notice from: 04/07/2025 from 08:00 to 17:59 hs
Proposal Delivery: From 04/07/2025 to 08:00
Calcical AdoorVastatin, dosage 40 mg
Quantity: 1800
Azathioprine, concentration 50 mg
Quantity: 260000
Calcitoninccb25dd379407458d1bf3bd9c3c3eda6 Synthetic, salmon composition, concentration 200 IU/dose, pharmaceutical form nasal spray
Quantity: 480
Cyclophosphamide, composition 50 mg
Quantity: 750
Cyclosporine, concentration 100 mg/ml, pharmaceutical form oral solution
Quantity: 12
Cyclosporine, concentration 25 mg
Quantity: 32400
Cyclosporine, Concentration 50 mg
Quantity: 4200
Ciprofibrate, dosage 100 mg
Quantity: 31320
Clobazam, dosage 10 mg
Quantity: 61200
Clobazam, dosage 20 mg
Dapagliflozine, 10 mg concentration
Quantity: 600000
FludroCortisone Acetate, dosage 0.1 mg
Quantity: 4000
Formoterol Fumarato, Composition associated with Budesonide, 12 mcg + 400mcg/dose concentration, pharmaceutical form inhalation capsule, additional characteristics with inhaler vial
Quantity: 1260000
Formoterol Fumarato, composition associated with Budesonide, concentration 6 mcg +200 mcg/dose, pharmaceutical form suspension Aerosol for inhalation, additional characteristics with inhaler vial
Quantity: 201600
GABAPENTINE, DOSAGE 300 MG
Quantity: 150000
GABAPENTINE, DOSAGE 400 MG
Quantity: 214980
Hydroxychlorine sulfate, dosage 400 mg
Quantity: 48000
Isotretinoin, dosage 20 mg
Quantity: 38400
Lamotrigine, Dosage 25 mg
Quantity ...
Documents
Tender Notice